author-photo

William Cross

St James's University Hospital
Leeds Teaching Hospitals NHS Trust

49

Papers

2632

Citations

Citation Trend

Filter By

Papers (49) Sort By

Journal Conference Others

LBA4 Abiraterone acetate plus prednisolone (AAP) with or without enzalutamide (ENZ) added to androgen deprivation therapy (ADT) compared to ADT alone for men with high-risk non-metastatic (M0) prostate cancer (PCa): Combined analysis from two comparisons in the STAMPEDE platform protocol

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial

2020 The Lancet
Show All
- Source
- Cite
- Save
Citations (70)
Decision regret in men living with and beyond non‐metastatic prostate cancer in the UK: a population‐based patient‐reported outcome study

2020 Psycho-oncology
Show All
- Source
- Cite
- Save
Citations (6)
Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group

2020 Journal of bone oncology
Show All
- Source
- Cite
- Save
Citations (7)
Patterns of lymph node failure in recurrent prostate cancer patients post radical prostatectomy and implications for salvage therapies

2020 Advances in radiation oncology
Show All
- Source
- Cite
- Save
Citations (5)
Haptics in Surgical Robots

2020
Show All
- Source
- Cite
- Save
Citations (1)
Experiences of support for sexual dysfunction in men with prostate cancer: findings from a UK-wide mixed methods study

2020 The Journal of Sexual Medicine
Show All
- Source
- Cite
- Save
Citations (1)
Best practice in active surveillance for men with prostate cancer: a prostate cancer UK consensus statement

2019 BJUI
Show All
- Source
- Cite
- Save
Citations (16)
Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study

2019 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (59)
The role of abiraterone acetate plus prednisone/prednisolone in high- and low-risk metastatic hormone sensitive prostate cancer

2019 European Urology Supplements
Show All
- Source
- Cite
- Save
Citations (1)